CHAD HUBERTY: Open Payments
NPI 1407852304 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 58 payments from 23 companies in 2025. Trend: 2023 $1,589 · 2024 $2,007 · 2025 $1,145
Food & beverage: $1,145
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $178 |
| UCB, Inc. | 8 | $162 |
| Novartis Pharmaceuticals Corporation | 10 | $156 |
| Radius Health, Inc. | 4 | $87 |
| PFIZER INC. | 5 | $66 |
| ABBVIE INC. | 3 | $63 |
| Madrigal Pharmaceuticals | 1 | $44 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Mallinckrodt Hospital Products Inc. | 1 | $31 |
Products named: Bimzelx, COSENTYX, Wegovy, Tymlos, Ozempic, PREVNAR 20, REZDIFFRA, VRAYLAR.
Industry payments across SC — which companies pay providers there.
